Japan has been testing TRG035, an antibody designed to block USAG 1, a protein involved in regulating tooth development. The research aims to stimulate dormant tooth forming capacity, particularly in people born without some teeth. A Phase I clinical trial in healthy adults began in 2024 and focused primarily on safety and pharmacokinetics alone. MLA source: Japan Registry of Clinical Trials. “Phase I Single Administration Study of TRG035 in Healthy Adults.” National Institute of Public Health, 2024. Want more interesting content like this ? Follow gravitonomy :) #japan #dentures #teeth #science #dentist